X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (16) 16
humans (13) 13
aged (11) 11
female (11) 11
male (11) 11
oncology (10) 10
adult (9) 9
chemotherapy (9) 9
middle aged (9) 9
cancer (7) 7
research (7) 7
care and treatment (6) 6
lung cancer (6) 6
lung cancer, non-small cell (6) 6
medicine, general & internal (6) 6
cancer therapies (5) 5
disease-free survival (5) 5
lung neoplasms - drug therapy (5) 5
survival (5) 5
antineoplastic combined chemotherapy protocols - adverse effects (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
carcinoma, non-small-cell lung - drug therapy (4) 4
docetaxel (4) 4
health aspects (4) 4
immunotherapy (4) 4
metastasis (4) 4
mutation (4) 4
neoplasm staging (4) 4
patients (4) 4
treatment outcome (4) 4
accuracy (3) 3
aged, 80 and over (3) 3
breast cancer (3) 3
clinical trials (3) 3
double-blind method (3) 3
gemcitabine (3) 3
hematology, oncology and palliative medicine (3) 3
lung neoplasms - pathology (3) 3
nivolumab (3) 3
nsclc (3) 3
platinum (3) 3
retrospective studies (3) 3
sensitivity and specificity (3) 3
time factors (3) 3
tumors (3) 3
validity (3) 3
1506 (2) 2
1730 (2) 2
abridged index medicus (2) 2
administrative database (2) 2
adolescent (2) 2
alfacalcidol (2) 2
analysis (2) 2
antibodies, monoclonal - administration & dosage (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
assessment (2) 2
bevacizumab (2) 2
breast-cancer (2) 2
calcifediol (2) 2
cancer research (2) 2
carboplatin (2) 2
carcinoma, non-small-cell lung - pathology (2) 2
codes (2) 2
cross-sectional studies (2) 2
data bases (2) 2
disease (2) 2
disease progression (2) 2
erlotinib (2) 2
europe (2) 2
exercise (2) 2
health risk assessment (2) 2
hospitals (2) 2
iii trial (2) 2
italy - epidemiology (2) 2
kaplan-meier estimate (2) 2
life (2) 2
lung neoplasms - diagnosis (2) 2
medical prognosis (2) 2
medicine (2) 2
mortality (2) 2
multicenter (2) 2
non-small cell lung cancer (2) 2
non-small cell lung carcinoma (2) 2
observational study (2) 2
open-label (2) 2
placebos (2) 2
prevention (2) 2
product development (2) 2
prospective studies (2) 2
quality of life (2) 2
relapse (2) 2
research methods (2) 2
safety (2) 2
studies (2) 2
survival rate (2) 2
toxicity (2) 2
validation (2) 2
vitamin d (2) 2
young adult (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2014, Volume 384, Issue 9944, pp. 665 - 673
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 3, pp. 247 - 255
Journal Article
Lancet Respiratory Medicine, The, ISSN 2213-2600, 2017, Volume 5, Issue 5, pp. 435 - 444
Journal Article
by Bellelli, Giuseppe and Morandi, Alessandro and Di Santo, Simona G and Mazzone, Andrea and Cherubini, Antonio and Mossello, Enrico and Bo, Mario and Bianchetti, Angelo and Rozzini, Renzo and Zanetti, Ermellina and Musicco, Massimo and Ferrari, Alberto and Ferrara, Nicola and Trabucchi, Marco and Boffelli, Stefano and Stefano, Fabio Di and Filippi, Francesco De and Guerini, Fabio and Bertoletti, Erik and March, Albert and Margiotta, Alessandro and Mecocci, Patrizia and Addesi, Desireè and Fantò, Fausto and Dijik, Babette and Porrino, Paola and Cotroneo, Antonino Maria and Galli, Giovanni and Bruni, Amalia Cecilia and Bernardini, Bruno and Corsini, Carla and Cagnin, Annachiara and Zurlo, Amedeo and Barbagallo, Giuseppe and Lunardelli, Maria Lia and Martini, Emilio and Battaglia, Giuseppe and Latella, Raffaele and Petritola, Donatella and Sinforiani, Elena and Cester, Alberto and Formilan, Marino and Carbone, Pasqualina and Appollonio, Ildebrando and Cereda, Diletta and Tremolizzo, Lucio and Bottacchi, Edo and Lucchetti, Lucio and Mariani, Claudio and Rapazzini, Piero and Romanelli, Giuseppe and Marengoni, Alessandra and Zuliani, Giovanni and Bianchi, Lara and Suardi, Teresa and Muti, Ettore and Bottura, Renato and Sgrò, Giovanni and Mandas, Antonella and Serchisu, Luca and Crippa, Patrizia and Ivaldi, Claudio and Ungar, Andrea and Villani, Daniele and Raimondi, Clara and Mussi, Chiara and Isaia, Giancarlo and Provenzano, Giuseppe and Mari, Daniela and Odetti, Patrizio and Monacelli, Fiammetta and Incalzi, Raffaele Antonelli and Pluderi, Alice and Bellamoli, Claudio and Terranova, Luciano and Scarpini, Elio and D'Amico, Ferdinando and Cavallini, Maria Chiara and Guerrini, Gianbattista and Scotuzzi, Anna Maria and Chiarello, Antonino and Pilotto, Alberto and Tognini, Sara and Dell'Aquila, Giuseppina and Toigo, Gabriele and Ceschia, Giuliano and Piccinini, Maristella and Fabbo, Andrea and Zoli, Marco and Forti, Paola and Wenter, Christian and Basile, Giorgio and Lasagni, Anna and Padovani, Alessandro and Rozzini, Luca and Cottino, Maria and Vitali, Silvia and Tripi, Gabriele and Avanzi, Stefano and Annoni, Giorgio and ... and Italian Study Grp Delirium ISGoD and Italian Study Group on Delirium (ISGoD)
BMC Medicine, ISSN 1741-7015, 07/2016, Volume 14, Issue 1, p. 106
Journal Article
by Garassino, Marina Chiara and Cho, Byoung-Chul and Kim, Dong-Wan and Kim, Joo-Hang and Kim, Sang-We and Kim, Young-Chul and Mazières, Julien and Vansteenkiste, Johan and Lena, Hervé and Corral Jaime, Jesus and Gray, Jhanelle E and Powderly, John and Chouaid, Christos and Bidoli, Paolo and Wheatley-Price, Paul and Park, Keunchil and Soo, Ross A and Huang, Yifan and Wadsworth, Catherine and Dennis, Phillip A and Rizvi, Naiyer A and Paz-Ares Rodriguez, Luis and Novello, Silvia and Hiret, Sandrine and Schmid, Peter and Laack, Eckart and Califano, Raffaele and Maemondo, Makoto and Chaft, Jamie and Vicente Baz, David and Berghmans, Thierry and Surmont, Veerle and Reck, Martin and Han, Ji-Youn and Holgado Martin, Esther and Belda Iniesta, Cristobal and Oe, Yuichiro and Chella, Antonio and Chopra, Akhil and Robinet, Gilles and Soto Parra, Hector and Thomas, Michael and Cheema, Parneet and Katakami, Nobuyuki and Su, Wu-Chou and Wolf, Juergen and Lee, Jong-Seok and Saka, Hideo and Milella, Michele and Ramos Garcia, Inmaculada and Sibille, Anne and Yokoi, Takashi and Kang, Eun Joo and Atagi, Shinji and Spaeth-Schwalbe, Ernst and Nishio, Makoto and Imamura, Fumio and Gabrail, Nashat and Veillon, Remi and Derijcke, Sofie and Maeda, Tadashi and Zylla, Dylan and Kubiak, Kendra and Santoro, Armando and Uy, Ma. Noemi and Lucien Geater, Sarayut and Italiano, Antoine and Kowalski, Dariusz and Barlesi, Fabrice and Chen, Yuh-Min and Spigel, David and Chewaskulyong, Busyamas and Garcia Gomez, Ramon and Alvarez Alvarez, Rosa and Yang, Chih-Hsin and Hsia, Te-Chun and Denis, Fabrice and Sakai, Hiroshi and Vincent, Mark and Goto, Koichi and Bosch-Barrera, Joaquim and Weiss, Glen and Canon, Jean-Luc and Scholz, Christian and Aglietta, Massimo and Kemmotsu, Hirotsugu and Azuma, Koichi and Bradbury, Penelope and Feld, Ronald and Chachoua, Abraham and Jassem, Jacek and Juergens, Rosalyn and Palmero Sanchez, Ramon and Malcolm, Albert and Vrindavanam, Nandagopal and Kubota, Kaoru and Waller, Cornelius and Waterhouse, David and Coudert, Bruno and Mark, Zsuzsanna and ... and ATLANTIC Investigators
The Lancet Oncology, ISSN 1470-2045, 04/2018, Volume 19, Issue 4, pp. 521 - 536
Immune checkpoint inhibitors are a new standard of care for patients with advanced non-small-cell lung cancer (NSCLC) without tyrosine kinase or anaplastic... 
MULTICENTER | METAANALYSIS | NSCLC | ONCOLOGY | RANDOMIZED CONTROLLED-TRIAL | ATEZOLIZUMAB | IMMUNE CHECKPOINT | NIVOLUMAB | MEDI4736 | CLINICAL ACTIVITY | DOCETAXEL | Lung cancer, Non-small cell | Care and treatment
Journal Article
Future Oncology, ISSN 1479-6694, 09/2018, Volume 14, Issue 22, pp. 2303 - 2317
ALK positivity, despite representing only in a small proportion of patients with non-small-cell lung cancer, is worth researching at diagnosis given the... 
NSCLC | ALK inhibitors | ALK TKI resistance | GROWTH-FACTOR-RECEPTOR | GENE REARRANGEMENTS | EML4-ALK FUSION | IN-SITU HYBRIDIZATION | ACQUIRED-RESISTANCE | OPEN-LABEL | EGFR MUTATION | ANAPLASTIC LYMPHOMA KINASE | ONCOLOGY | RESPONSE DURATION | POLYMERASE CHAIN-REACTION
Journal Article
British Journal of Cancer, ISSN 0007-0920, 09/2016, Volume 115, Issue 7, pp. 789 - 796
Background: Immune Modulation and Gemcitabine Evaluation-1, a randomised, open-label, phase II, first-line, proof of concept study (NCT01303172), explored... 
IMM-101 | phase II | immunomodulator | pancreatic cancer | advanced pancreatic ductal adenocarcinoma | Mycobacterium obuense | immunotherapy | gemcitabine | SURVIVAL | FOLFIRINOX | SAFETY | ADENOCARCINOMA | TRIAL | ONCOLOGY
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 7/2018, Volume 82, Issue 1, pp. 77 - 86
Ramucirumab plus docetaxel improved survival in REVEL, a randomized phase 3 trial for patients with Stage IV non-small cell lung cancer after standard... 
Medicine & Public Health | Non-small cell lung cancer | Docetaxel | Exposure–response | Oncology | Cancer Research | Ramucirumab | Pharmacology/Toxicology | Pharmacokinetics | ONCOLOGY | IMC-1121B | Exposure-response | PHARMACOLOGY & PHARMACY | OPTIMIZATION | Lung Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Docetaxel - adverse effects | Humans | Lung Neoplasms - metabolism | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Dose-Response Relationship, Drug | Young Adult | Docetaxel - administration & dosage | Adult | Female | Double-Blind Method | Kaplan-Meier Estimate | Antibodies, Monoclonal - pharmacokinetics | Docetaxel - pharmacokinetics | Antibodies, Monoclonal - administration & dosage | Progression-Free Survival | Adolescent | Aged | Neoplasm Staging | Antimitotic agents | Care and treatment | Chemotherapy | Analysis | Clinical trials | Lung cancer, Small cell | Product development | Metastasis | Lung cancer, Non-small cell | Antineoplastic agents | Cancer | Toxicity | Lung cancer | Statistical methods | Cancer therapies | Metastases | Randomization | Platinum | Quartiles | Safety | Significance | Neutropenia | Hypertension | Statistical analysis | Cell survival | Effectiveness | Causation | Non-small cell lung carcinoma | Pharmacology | Exposure | Regression analysis | Survival | Patients | Medical prognosis
Journal Article
Journal Article